Streptococcus Mutans Cariogenicity by Real-time PCR in High Caries Risk Patients

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04566120
Collaborator
(none)
37
1
2
13
2.8

Study Details

Study Description

Brief Summary

In patients with high caries risk, will the use of cinnamon extract or chlorohexidine based mouthwashes have an effect on the percentage of recovery and cariogenicity of Streptococcus mutans (SM) detected by real-time Polymerase Chain Reaction (PCR) over one month follow up

Condition or Disease Intervention/Treatment Phase
  • Drug: cinnamon extract mouthwash
  • Drug: chlorohexidine based mouthwash
N/A

Detailed Description

This clinical study will be held in the clinic of conservative dentistry department, Faculty of Dentistry, Cairo University. The operator in charge will be Mostafa Mahmoud El-Ghazali. Patients will be examined and selected according to inclusion and exclusion criteria, the purpose and method of the study will be explaned to the selected patients, written informed consent will be obtained from the patients for participation in the study. In the first visit, ADA caries risk assessment model will be done. Participants will be divided into two groups according to the tested mouthwashes.

All patients will be instructed not to have breakfast and to refrain any oral hygiene measures on the day of sample collection to avoid the influence of food consumption and contamination on the composition of saliva. The patient will sit in an erect position on the dental chair and will be given paraffin block to chew. The stimulated saliva will be collected after 2 minutes of paraffin chewing in sterile containers held near the mouth. The containers will be properly labeled. The study will be carried over a period of one month, the saliva samples for each patient will be collected on the first dental visit. These samples will be then sent to the laboratory for microbiological assessment. Patients will be provided with mouthwashes according to the tested groups and they will be instructed to use it 2 times per day for 1 minute each time and no eating or drinking permitted for a minimum of 30 minutes post rinsing. Each patient will be given the same instructions with respect to oral hygiene measures. They will be advised to continue on same diet and will be instructed not to change their dietary habits. Patients will come after 2 weeks for salivary samples collection and samples will be sent to the laboratory for microbiological assessment. After treatment continuity for another 2 weeks, patients will come for the last visit to collect the salivary samples which will be sent to the laboratory for microbiological assessment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
37 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Detection of Streptococcus Mutans Cariogenicity by Real-time PCR in High Caries Risk Patients Using Cinnamon Extract or Chlorohexidine Mouthwashes: A Randomized Clinical Trial
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Feb 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cinnamon extract mouthwash

Participants will be exposed to cinnamon extract mouthwash and will be instructed to use 10 ml of cinnamon extract mouthwash 2 times per day for 1 minute; such a regimen will be continued for one month.

Drug: cinnamon extract mouthwash
cinnamon extract mouthwash
Other Names:
  • Natural Product Mouthwash
  • Active Comparator: Chlorohexidine based mouthwash

    Participants will be exposed to chlorohexidine based mouthwash. and will be instructed to use 10 ml of 0.12% chlorhexidine based mouthwash 2 times per day for 1 minute; such a regimen will be continued for one month.

    Drug: chlorohexidine based mouthwash
    chlorohexidine based mouthwash
    Other Names:
  • Synthetic Mouthwash
  • Outcome Measures

    Primary Outcome Measures

    1. Total bacterial count [1 month]

      quantitative plating (standard plate count or SPC)n will be used to determine the number of bacteria in a culture sample. SPC reveals information on viable organisms only; bacteria colonies that are seen in the plates after incubation represent only living organisms, not dead ones.

    Secondary Outcome Measures

    1. Bacterial Identification [1 month]

      Total extraction of DNA: Total plasmid DNA will be prepared. The solution will be centrifuged and then left at room temperature for few minutes for the phase separations. The aqueous phase containing DNA will be transferred to clean eppendorf. PCR Polymerase chain reaction: The PCR will be performed in 25µl reaction volume containing: DNA template, enzymes, primer and nuclease-free water. The tubes containing the PCR mixture will be transferred to the thermal cycler apparatus. The PCR products will be analyzed in agarose gel by electrophoresis, photographed and analyzed.

    2. Total protein profile [1 month]

      Proteins can be separated according to their molecular weights by Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Adults will be recruited in this study, all the volunteers participated in this experiment will be healthy looking with free medical history.

    • Age range 20-50 years

    • High caries risk patients according to ADA caries risk assessment model.

    • High plaque index (>score 2)

    • Non-smoking patients.

    • Patients with normal salivary rate (0.3-0.4 ml/min).

    Exclusion Criteria:
    • Patients with a compromised medical history.

    • Participants with low caries risk.

    • Patients with severe or active periodontal disease.

    • Participants with a history of allergy to any of the drugs or chemicals used in the study.

    • Patients on any antibiotics during the past month

    • Smoking patients.

    • Patients with abnormal salivary rate.

    • Pregnant female patients

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cairo Uniuversity Giza Egypt

    Sponsors and Collaborators

    • Cairo University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mostafa Mahmoud Mohamed Kamel El-Ghazali, Principle Investigator, Cairo University
    ClinicalTrials.gov Identifier:
    NCT04566120
    Other Study ID Numbers:
    • oper131
    First Posted:
    Sep 28, 2020
    Last Update Posted:
    Sep 13, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Sep 13, 2021